nach oben

Digestive Diseases and Sciences

Erschienen in:

27.07.2021 | Editorial

Does Surveillance Increase Survival? Benefits of Periodic Colonoscopy in Patients with Ulcerative Colitis and Colorectal Cancer

verfasst von: Michael J. Stewart

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Excerpt

The development of colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD) has long been recognized as a complication of chronic colitis. Nearly a century ago, Dr. Burrell Crohn described carcinomatous degeneration of the bowel as the terminal stage of ulcerative colitis (UC) [1]. While data from mid-twentieth century suggested markedly high rates of CRC, there has been a steady decline in estimated incidence rates in recent decades, with a 2012 meta-analysis of population-based studies estimating 2.4-fold increased risk compared with the general population [2]. …

Crohn BB, Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am J Med Sci 1925;170:220–227.CrossRef

Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–645.CrossRef

Feagins LA, Souza RF, Spechler SJ. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol. 2009;6:297–305.CrossRef

Hu AB, Burke KE, Kochar B, Ananthakrishnan AN. Yield of random biopsies during colonoscopies in inflammatory bowel disease patients undergoing dysplasia surveillance. Inflamm Bowel Dis. 2021;27:779–786.CrossRef

Fumery M, Dulai PS, Gupta S, Prokop LJ, Ramamoorthy S, Sandborn WJ et al. Incidence, risk factors, and outcomes of colorectal cancer in patients with ulcerative colitis with low-grade dysplasia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15:665-674.e5.CrossRef

Karlén P, Kornfeld D, Broström O, Löfberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998;42:711–714.CrossRef

Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol. 1990;85:1083–1087.PubMed

Lutgens M, Oldenburg B, Siersema PD, Van Bodegraven AA, Dijkstra G, Hommes DW et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer. 2009;101:1671–1675.CrossRef

Campieri M, Gionchetti P, Belluzzi A, Brignola C, Tampieri M, Iannone P et al. Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation A double-blind placebo controlled trial. Int J Color Dis. 1990;5:79–81.CrossRef

10.

Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S et al. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;13:322–329.CrossRef

11.

Narula N, Hu A, Nguyen GC, Rangrej J, Marshall JK. Periodic colonoscopies are associated with improved survival and prognosis of colorectal cancer in ulcerative colitis. Dig Dis Sci. (Epub ahead of print). doi: https://doi.org/10.1007/s10620-021-07151-7.

12.

Choi PM, Nugent FW, Schoetz DJ, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418–424.CrossRef

13.

Bye WA, Nguyen TM, Parker CE, Jairath V, East JE. Strategies for Detecting Colon Cancer in Patients with Inflammatory Bowel Disease. Vol. 2017, Cochrane Database of Systematic Reviews. 2017.

Titel: Does Surveillance Increase Survival? Benefits of Periodic Colonoscopy in Patients with Ulcerative Colitis and Colorectal Cancer
verfasst von: Michael J. Stewart
Publikationsdatum: 27.07.2021
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 5/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-021-07174-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

20.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Does Surveillance Increase Survival? Benefits of Periodic Colonoscopy in Patients with Ulcerative Colitis and Colorectal Cancer

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2022

Gastrointestinal Endoscopy-Associated Infections: Update on an Emerging Issue

State-of-the-Art Update of Pancreatic Cysts

Increased Risk of Advanced Colonic Adenomas and Timing of Surveillance Colonoscopy Following Solid Organ Transplantation

Artificial Intelligence in Endoscopy

When ERCP Fails: EUS-Guided Access to Biliary and Pancreatic Ducts

Australasian Pediatric Gastroenterologists’ Perspectives and Practices of Celiac Disease Diagnosis and Management

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Update Innere Medizin